Lentine Krista L, Schnitzler Mark A, Abbott Kevin C, Li Leiming, Burroughs Thomas E, Irish William, Brennan Daniel C
Center for Outcomes Research, Division of Nephrology, Saint Louis University School of Medicine, St Louis, MO, USA.
Am J Kidney Dis. 2005 Oct;46(4):720-33. doi: 10.1053/j.ajkd.2005.06.019.
We aim to describe the risk, predictors, and outcomes associated with de novo congestive heart failure (CHF) after kidney transplantation.
We used registry data from the US Renal Data System to retrospectively investigate de novo CHF in adult Medicare-insured transplant recipients and wait-listed candidates in 1995 to 2001. Heart failure was ascertained from inpatient and outpatient billing records, and participants were followed up until loss of Medicare or December 31, 2001. We used extended Cox hazards analysis to identify independent correlates of posttransplantation de novo CHF (adjusted hazard ratio [AHR], 95% confidence interval [CI]) and examine de novo CHF as a predictor of death and graft loss after transplantation.
In 27,011 transplant recipients, cumulative incidences of de novo CHF were 10.2% (95% CI, 9.8 to 10.6) and 18.3% (95% CI, 17.8 to 18.9) at 12 and 36 months and decreased to less than the demographic-adjusted incidence on the waiting list beyond the early posttransplantation period. Risk factors for de novo CHF included older recipient age, female sex, unemployed status at transplantation, pretransplantation comorbidities (anemia, diabetes mellitus, myocardial infarction, angina, cardiac arrhythmia, and peripheral vascular disease), transplant from older donors, donor cardiovascular death, and delayed graft function. We identified pretransplantation obesity, smoking, and posttransplantation complications, including hypertension, anemia, new-onset diabetes, myocardial infarction, and graft failure, as potentially modifiable correlates of de novo CHF. In separate analyses, de novo CHF predicted death (AHR, 2.6; 95% CI, 2.4 to 2.9) and death-censored graft failure (AHR, 2.7; 95% CI, 2.4 to 3.0).
Although associations may not reflect causality, identification of potentially mutable de novo CHF risk factors suggests targets for improving outcomes that should be evaluated prospectively.
我们旨在描述肾移植后新发充血性心力衰竭(CHF)的风险、预测因素及结局。
我们使用美国肾脏数据系统的登记数据,对1995年至2001年期间参加医疗保险的成年肾移植受者及列入等待名单的候选者中的新发CHF进行回顾性研究。心力衰竭通过住院和门诊计费记录确定,对参与者进行随访直至失去医疗保险或2001年12月31日。我们使用扩展Cox风险分析来确定移植后新发CHF的独立相关因素(调整后风险比[AHR],95%置信区间[CI]),并将新发CHF作为移植后死亡和移植物丢失的预测因素进行研究。
在27011名移植受者中,新发CHF的累积发生率在12个月和36个月时分别为10.2%(95%CI,9.8至10.6)和18.3%(95%CI,17.8至18.9),在移植后早期过后降至低于按人口统计学调整的等待名单发生率。新发CHF的危险因素包括受者年龄较大、女性、移植时失业状态、移植前合并症(贫血、糖尿病、心肌梗死、心绞痛、心律失常和外周血管疾病)、来自老年供者的移植、供者心血管死亡和移植肾功能延迟。我们确定移植前肥胖、吸烟以及移植后并发症,包括高血压、贫血、新发糖尿病、心肌梗死和移植物衰竭,为新发CHF的潜在可改变相关因素。在单独分析中,新发CHF可预测死亡(AHR,2.6;95%CI,2.4至2.9)和死亡删失的移植物衰竭(AHR,2.7;95%CI,2.4至3.0)。
尽管相关性可能不反映因果关系,但识别潜在可变的新发CHF危险因素提示了改善结局的目标,应进行前瞻性评估。